## Abstract ## Background The CAMCOG is a brief neuropsychological battery designed to assess global cognitive function and ascertain the impairments that are required for the diagnosis of dementia. To date, the cutβoff scores for mild cognitive impairment (MCI) have not been determined. Given the
DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia
β Scribed by E. Kalbe; J. Kessler; P. Calabrese; R. Smith; A. P. Passmore; M. Brand; R. Bullock
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 107 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1042
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objectives
To design a new, highly sensitive psychometric screening to identify patients with mild cognitive impairment (MCI) and patients with dementia in the early stages of the disease.
Methods
Five tasks were included in the DemTect: a word list, a number transcoding task, a word fluency task, digit span reverse, and delayed recall of the word list. The normation was performed with 145 healthy control subjects (CG). Furthermore, 97 MCI patients and 121 patients with possible Alzheimer's disease (AD) were tested with the DemTect and the MMSE. Classification rates for both tests were analysed.
Results
On the basis of the CG data, ageβdependant transformation algorithms for the DemTect subtests were defined, and an education correction was provided for the total transformed score. The patient groups scored significantly below the CG in both the DemTect and the MMSE. Compared to the MMSE, classification rates of the DemTect were superior for both the MCI and the AD group, with high sensitivities of 80% and 100%, respectively.
Conclusions
The DemTect is short (8β10 minutes), easy to administer, and its transformed total score (maximum 18) is independent of age and education. The DemTect helps in deciding whether cognitive performance is adequate for age (13β18 points), or whether MCI (9β12 points) or dementia (8 points or below) should be suspected. Copyright Β© 2004 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract ## Objective To examine the reliability and validity of the mCDR, a modified version of the clinical dementia rating (CDR) scale. ## Methods The mCDR is an informantβbased, technicianβadministered, structured interview with multiple choice responses, which does not include objective
## Abstract ## Background Mild cognitive impairment (MCI) is a condition referring to the persons with cognitive deficits measurable in some form or another, but not meeting criteria for dementia, and who have an increased risk of becoming demented. ## Objective To establish the rate of progress
## Abstract ## Background Subjective memory complaints (SMC) are frequently reported by individuals with objective evidence of cognitive decline although the exact rate of complaints and their diagnostic value is uncertain. ## Method A metaβanalysis was conducted for all studies examining SMC an
## Abstract ## Objectives To design and validate a new screening test for amnestic Mild Cognitive Impairment (AβMCI) and early stage Alzheimer's disease (AD). ## Methods We develop a verbal episodic and semantic memory test: the Memory Alteration Test (M@T). Discriminative validity was assessed